1-4 of 4
Reyad Dada, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single Institutional Experience with Nivolumab in Relapsed/Refractory Classic Hodgkin

Reyad Dada, MD, Bassim T. Malas Al-Beirouti, MD MSc, FRCPC, Yazeed Zabai
Journal: Blood
Blood (2018) 132 (Supplement 1): 5355.
https://doi.org/10.1182/blood-2018-99-110259
Published: 2018
Journal Articles

Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma Patients: Single Institutional Experience

Reyad Dada, MD, Aisha Alharbi, MD, Ehab Mosaaf, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5356.
https://doi.org/10.1182/blood-2018-99-110262
Published: 2018
Journal Articles

Outpatient Fractionated ICE Protocol in Relapsed/Refractory Lymphomas: Efficacy and Safety

Reyad Dada, MD, Azhar Nawaz, Clinical Pharmacy Specialist, Ehab Mosaad Abdelghany, MD, Tarek Boubakra
Journal: Blood
Blood (2018) 132 (Supplement 1): 5357.
https://doi.org/10.1182/blood-2018-99-111538
Published: 2018
Journal Articles

Allogeneic Stem Cell Transplantation after Exposure to Checkpoint Inhibitors: Graft Versus Host Disease and Non-Relapse Mortality in Pooled Analysis

Reyad Dada, MD, Usman Binyam
Journal: Blood
Blood (2018) 132 (Supplement 1): 2124.
https://doi.org/10.1182/blood-2018-99-110261
Published: 2018